Review
Open access
Aug 2026
The estrogen-integrin αvβ3 crosstalk in breast cancer: Modulating PD-L1 and immune evasion.
A novel "dual-track" regulatory model is proposed to resolve the conflicting roles of estrogen in tumor immunity and novel molecular targets are uncovered to improve combined endocrine and immunotherapeutic regimens for breast cancer patients.
Dana R. Crawford, Yung-Ning Yang, Feng-Cheng Liu et al.
· Biomedicine & pharmacotherap... · 0 citations